cresemba powder for concentrate for solution for infusion 200mg
pfizer private limited - isavuconazonium sulfate 372.6mg eqv isavuconazole - injection, powder, lyophilized, for solution - isavuconazonium sulfate 372.6mg eqv isavuconazole 200 mg
cresemba
pfizer new zealand limited - isavuconazonium sulfate 186.3mg equivalent to isavuconazole 100mg; - capsule - 100 mg - active: isavuconazonium sulfate 186.3mg equivalent to isavuconazole 100mg excipient: colloidal silicon dioxide disodium edetate gellan gum hypromellose ink black 10a2 iron oxide red magnesium citrate microcrystalline cellulose potassium acetate purified talc purified water sodium laurilsulfate stearic acid titanium dioxide - cresemba is indicated in adults for the treatment of: · invasive aspergillosis · mucormycosis in patients for whom amphotericin b is inappropriate consideration should be given to official guidance on the appropriate use of antifungal agents.
cresemba
pfizer new zealand limited - isavuconazonium sulfate 372.6mg equivalent to isavuconazole 200 mg; - powder for injection - 200 mg - active: isavuconazonium sulfate 372.6mg equivalent to isavuconazole 200 mg excipient: mannitol sulfuric acid - cresemba is indicated in adults for the treatment of: · invasive aspergillosis · mucormycosis in patients for whom amphotericin b is inappropriate consideration should be given to official guidance on the appropriate use of antifungal agents.
cresemba 200 milligram/1 vial
شركة أدوية الحكمة - hikma pharmaceuticals - isavuconazole 200 milligram/1 vial - 200 milligram/1 vial
cresemba 200mg powder for concentrate for solution for infusion vials
pfizer ltd - isavuconazonium sulfate - powder for solution for infusion - 200mg
cresemba 100mg capsules
pfizer ltd - isavuconazonium sulfate - capsule - 100mg
cresemba 186.3 mg capsule (equivalent to 100 mg isavuconazole)
n/a; importer: pfizer, inc.; distributor: n/a - isavuconazonium sulfate - capsule (equivalent to 100 mg isavuconazole) - 186.3 mg
cresemba powder for concentrate for solution for infusion 200mg
pfizer (malaysia) sdn. bhd. - isavucozanium sulfate -
cresemba 100mg capsule
pfizer (malaysia) sdn. bhd. - isavuconazonium sulfate -
itrazole
viatris limited - itraconazole 100mg; - capsule - 100 mg - active: itraconazole 100mg excipient: capsugel red g60csa00150 colloidal silicon dioxide ethanol gelatin hypromellose iron oxide red methylene chloride opacode white s-1-7078 purified water sorbitan stearate sugar spheres titanium dioxide - itraconazole capsules are indicated for the treatment of: · vulvovaginal candidiasis. · pityriasis versicolor, · dermatomycosis - including highly keratinised regions as in plantar tinea pedis and palmer tinea manus, · fungal keratitis, · oral candidiasis, · onychomycosis caused by dermatophytes and/or yeasts. · systemic mycoses, only in the following fungal infections: - systemic aspergillosis - histoplasmosis, - histoplasmosis, maintenance therapy only in aids patients - sporotrichosis (including lymphocutaneous/cutaneous and extracutaneous) - paraconccidioidomycosis, - chromomycosis, - blastomycosis